Hyperthermia-enhanced TRAIL- and mapatumumab-induced apoptotic death is mediated through mitochondria in human colon cancer cells
/in Colorectal Cancer, Hyperthermia, International Publications /von 2012-05-01 / J. Cell. Biochem. 2012 May;113(5):1547-58Hyperthermia induces cytoskeletal alterations and mitotic catastrophe in p53-deficient H1299 lung cancer cells
/in Hyperthermia, International Publications /von 2012-04-06 / Acta Histochem. 2013 Jan;115(1):8-15Re-irradiation plus regional hyperthermia for recurrent non-small cell lung cancer: a potential modality for inducing long-term survival in selected patients
/in Hyperthermia /von 2012-03-23 / Lung Cancer 2012 Jul;77(1):140-5Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses
/in Hyperthermia, International Publications, Ovarian Cancer /von 2012-02-13 / Toxicol. Sci. 2012 May;127(1):139-49Effector CD8+ T cell IFN-γ production and cytotoxicity are enhanced by mild hyperthermia
/in Hyperthermia, International Publications /von 2012-01-01 / Int J Hyperthermia 2012;28(1):9-18Inhibition of checkpoint kinase 1 abrogates G2/M checkpoint activation and promotes apoptosis under heat stress
/in Hyperthermia, International Publications /von 2012-01-01 / Apoptosis 2012 Jan;17(1):102-12Tumor response and negative distal resection margins of rectal cancer after hyperthermochemoradiation therapy
/in Colorectal Cancer, Hyperthermia, International Publications /von 2011-11-01 / Anticancer Res. 2011 Nov;31(11):3963-7Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial
/in Hyperthermia, International Publications, Pancreatic Cancer /von 2011-09-19 / Strahlenther Onkol 2011 Oct;187(10):619-25Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermia
/in Hyperthermia, International Publications /von 2011-08-26 / J. Leukoc. Biol. 2011 Nov;90(5):951-62IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de